Ocugen, Inc. - Common Stock (NQ:OCGN)

1.020 +0.020 (+2.00%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

36 37 Next >

54 Biggest Movers From Yesterday ↗

July 20, 2021

Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon...

Via Benzinga

Why Shares of Ocugen Climbed Today ↗

July 19, 2021

The delta variant is lifting the tide of companies associated with COVID testing and prevention.

Via The Motley Fool

Topics Death

Ocugen Stock Is Well Past Its Expiration Date and It Shows ↗

July 16, 2021

There won’t be a market for COVAXIN in the US as vaccination rates continue moving up. OCGN stock doesn’t even warrant the price of a dollar.

Via InvestorPlace

Why Ocugen Shares Are Rallying Today ↗

July 15, 2021

Ocugen, Inc. (NASDAQ: OCGN) shares were advancing strongly Thursday after the biopharma issued a regulatory update. Pennsylvania-based Ocugen said it has initiated a rolling...

Via Benzinga

OCGN INVESTOR ALERT: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit

July 14, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Why Ocugen Stock Skyrocketed 339% in the First Half of 2021 ↗

July 14, 2021

The big jump resulted from the company's partnership with Bharat Biotech to commercialize COVID-19 vaccine Covaxin.

Via The Motley Fool

Ocugen’s Recent Vaccine Efficacy Results Should Have Traders Cheering ↗

July 12, 2021

While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate.

Via InvestorPlace

Why Shares of Ocugen Are Dropping Today ↗

July 09, 2021

Investors may be getting concerned about how long it may take for COVID-19 vaccine Covaxin to get approved.

Via The Motley Fool

The Outlook for Ocugen Stock Has Deteriorated Further ↗

July 07, 2021

Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short.

Via InvestorPlace

What's Next For Ocugen Stock As It Nears Key Resistance Level? ↗

July 06, 2021

Ocugen Inc. (NASDAQ: OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner Bharat Biotech reported...

Via Benzinga

42 Stocks Moving In Tuesday's Mid-Day Session ↗

July 06, 2021

Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline...

Via Benzinga

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

July 06, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory ↗

July 06, 2021

OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward.

Via InvestorPlace

OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today ↗

July 06, 2021

OCGN stock is racing higher this morning following better-than-expected results from Ocugen's vaccine partner. Here is what you need to know.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 06, 2021

Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella...

Via Benzinga

Ocugen Preps US Filings For COVID-19 Vaccine As New Data Shows Overall Efficacy Of Around 79% ↗

July 06, 2021

Armed with new data from its development partner Bharat Biotech, Ocugen Inc (NASDAQ: OCGN) plans to press ahead with plans to file for approval of their COVID-19...

Via Benzinga

28 Stocks Moving in Tuesday's Pre-Market Session ↗

July 06, 2021

Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE...

Via Benzinga

Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning! ↗

July 06, 2021

Growing trends involving OCGN stock suggest that the bears may have the upper hand this time.

Via InvestorPlace

Ocugen Has Had a Good Run, but the Math Says It’s Over ↗

July 06, 2021

Ocugen was a penny stock is up 180% for the year. But all good things must come to an end. And it’s time to let go of OCGN stock.

Via InvestorPlace

INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

July 05, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

3 Tips for Coronavirus Investing Right Now ↗

July 05, 2021

Whether you're a cautious or aggressive investor, there's something for you in this space.

Via The Motley Fool

Topics Cannabis

One Bright Spot for Ocugen Investors ↗

July 03, 2021

It may equal some coronavirus vaccine revenue ahead.

Via The Motley Fool

Topics Cannabis

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 02, 2021

Gainers Odonate Therapeutics (NASDAQ:ODT)...

Via Benzinga

INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

July 02, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Opportunity for Investors With Substantial Losses to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN

July 02, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

How Risky Is Ocugen After Its Recent Setback? ↗

July 02, 2021

The U.S. vaccine market has slipped farther out of reach.

Via The Motley Fool

Topics Cannabis

Better Short-Squeeze Stock: Clover Health or Ocugen? ↗

July 02, 2021

Both have the necessary ingredients for explosive short-squeeze returns.

Via The Motley Fool

Why Ocugen Shares Are Slipping Today ↗

July 01, 2021

It could be due to the aftereffects of being included in a major stock index.

Via The Motley Fool

INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

July 01, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Sell Ocugen Stock Before the Other Shoe Finally Drops ↗

June 30, 2021

The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated.

Via InvestorPlace

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.